Article
04 Mar 2026
The EEOC's Sex Discrimination Lawsuit Against Coca-Cola Beverages Northeast And Its Implication For Employers And DEI Initiatives
CONTRIBUTING SINCE MARCH 2011
Buchanan Ingersoll & Rooney PC
With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
POPULAR TOPICS
Food, Drugs, Healthcare, Life Sciences
Cannabis & Hemp
International Law
Employment and HR
Energy and Natural Resources
DETAILS
United States
+1 412 562 8800
Union Trust Building
501 Grant Street
Suite 200
Pittsburgh
United States
Contact Firm
COMPANY CONTENT
Article
04 Mar 2026
Florida School Agrees To Pay $1.7M For Sanctions Violations Related To Payment Of International Students' Tuition
Article
02 Mar 2026
Patent Term Adjustment, IDSs And The 30-Day Rule
Article
27 Feb 2026
CSC Issues Guidance On NIL Enforcement As The Transfer Portal Heats Up
Article
27 Feb 2026
IEEPA Tariffs Are Out – Assessing What Comes Next
Article
27 Feb 2026
Rounding Hours And FLSA Compliance: Essential Considerations For Employers Overview
Article
26 Feb 2026
Senate HELP Committee Releases FDA Modernization Report: "Patients And Families First: Building The FDA Of The Future"
Article
26 Feb 2026
Corcept Therapeutics v. Teva Pharmaceuticals: Going Outside The Label To Show No Direct Infringement
Article
24 Feb 2026
Massachusetts Introduces Legislation To Regulate Pharmacy Benefit Managers
Article
23 Feb 2026
HTI-5: The Great Health IT Deregulation – What Healthcare Companies Need To Know Now
Article
23 Feb 2026
FDA Announces New Enforcement Policy On "No Artificial Colors" Food Labeling
Article
20 Feb 2026
Sweeping PBM Reforms Arrive: What The 2026 Federal Legislation Means For Pharmacies, Patients And Employers
Article
19 Feb 2026
New Jersey Appellate Division Clarifies Scope Of Ending Forced Arbitration Of Sexual Assault And Harassment Act
Article
13 Feb 2026
Oral Semaglutide And The GLP-1 Compounding Reckoning: From Regulatory Ambiguity To FDA Enforcement, DOJ Referrals, And Novo Nordisk's Case Against Hims & Hers
Article
13 Feb 2026
Legal Battles In College Sports: Enforcement Of NIL Contracts And The Future Of Athlete-Institution Agreements
Article
11 Feb 2026
Key Amendments To Arizona Laws Impacting The Pharmacy Industry
Article
06 Feb 2026
FY 2027 H-1B Cap Registration Opens March 4, 2026: Key Changes And Action Items
Article
03 Feb 2026
Client Update: Supreme Court Takes Up Skinny Labels Granting Certiorari In Hikma v. Amarin
Article
03 Feb 2026
The New NLRB "Screening" Phase Increases Risk Of Summary Dismissal
Article
30 Jan 2026
The Class Action Bar Is Starting To Target The Cannabis Industry For Potential Privacy Violations
AWARDS
